Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
暂无分享,去创建一个
Eytan Domany | Orit Pappo | Gidi Rechavi | Ninette Amariglio | E. Domany | N. Amariglio | E. Galun | J. Jacob-Hirsch | O. Pappo | L. Mitchell | D. Goldenberg | Lina Mizrahi | R. Kohen | G. Rechavi | Eithan Galun | Daniel Goldenberg | Jasmine Jacob-Hirsch | Ron Kohen | Hila Barash | Lina Mizrahi | Mark Katzenellenbogen | Naama Klopstock | Devorah Olam | Leslie Ann Mitchell | H. Barash | Naama Klopstock | M. Katzenellenbogen | Devorah Olam | Hila Barash | Gidi Rechavi
[1] K. Zatloukal,et al. [116] TAURINE-CONJUGATION CRITICALLY DETERMINES THE THERAPEUTIC EFFECTIVENESS OF 24-NOR-URSODEOXYCHOLIC ACID (NORUDCA) IN THE TREATMENT OF SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) KNOCKOUT MICE , 2007 .
[2] Michael Karin,et al. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.
[3] C. Jobin,et al. Serum amyloid A activates NF‐κB and proinflammatory gene expression in human and murine intestinal epithelial cells , 2005, European journal of immunology.
[4] J. Scher,et al. 15d-PGJ2: the anti-inflammatory prostaglandin? , 2005, Clinical immunology.
[5] Michael A. Gonzalez,et al. Cell‐cycle‐dependent regulation of DNA replication and its relevance to cancer pathology , 2005, The Journal of pathology.
[6] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[7] N. Devoogdt,et al. Secretory Leukocyte Protease Inhibitor in Cancer Development , 2004, Annals of the New York Academy of Sciences.
[8] S. Thorgeirsson,et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer , 2004, Nature Genetics.
[9] J. Bocco,et al. A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function , 2004, Oncogene.
[10] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[11] D. Megías,et al. Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumor Progression , 2004, Cancer Research.
[12] Y. Kloog,et al. Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.
[13] H. Tilg,et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2004, Gastroenterology.
[14] S. Friedman,et al. Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1 , 2004, Cancer Research.
[15] N. McElvaney,et al. Secretory Leucoprotease Inhibitor Impairs Toll-Like Receptor 2- and 4-Mediated Responses in Monocytic Cells , 2004, Infection and Immunity.
[16] I. Cho,et al. Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-γ and Retinoid X Receptor Heterodimer , 2004, Cancer Research.
[17] D. A. Foster,et al. The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] G. Souza,et al. Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. , 2004, Immunology letters.
[19] J. Klaunig,et al. The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.
[20] M. Reitman,et al. Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.
[21] S. Safe,et al. Peroxisome Proliferator-activated Receptor γ Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor α in MCF-7 Breast Cancer Cells , 2003 .
[22] B. Brewer,et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. , 2003, The Journal of clinical investigation.
[23] Qingxian Lu,et al. Macrophage regulation by Tyro 3 family receptors. , 2003, Current opinion in immunology.
[24] E. Wagner,et al. Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.
[25] F. Gonzalez,et al. Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor γ1 (PPARγ1) Overexpression* , 2003, The Journal of Biological Chemistry.
[26] J. Reddy,et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. , 2003, The Journal of biological chemistry.
[27] M. Oren,et al. Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53. , 2003, Cancer research.
[28] R. Eckel,et al. Lipoprotein lipase : genetics , lipid uptake , and regulation , 2002 .
[29] J. Auwerx,et al. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases , 2002, The Lancet.
[30] Y. Kloog,et al. Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.
[31] M. Aviram,et al. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. , 2002, Atherosclerosis.
[32] Y. Shyr,et al. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. , 2001, Cancer research.
[33] S. Hirono,et al. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells. , 2001, Cancer research.
[34] Y. Nishizuka. The protein kinase C family and lipid mediators for transmembrane signaling and cell regulation. , 2001, Alcoholism, clinical and experimental research.
[35] P. Kuo,et al. Osteopontin Is a Negative Feedback Regulator of Nitric Oxide Synthesis in Murine Macrophages1 , 2001, The Journal of Immunology.
[36] M. Sakaguchi,et al. Relationship between Contact Inhibition and Intranuclear S100c of Normal Human Fibroblasts , 2000, The Journal of cell biology.
[37] G. Getz,et al. Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Kawagoe,et al. Attenuation of luminol-amplified chemiluminescent intensity and lipid peroxidation in the livers of quercetin-fed mice. , 2000, Toxicology letters.
[39] O. Tirosh,et al. Quantification of the overall reactive oxygen species scavenging capacity of biological fluids and tissues. , 2000, Free radical biology & medicine.
[40] S. Thorgeirsson,et al. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[42] Blatt,et al. Superparamagnetic clustering of data. , 1998, Physical review letters.
[43] I. Weinstein. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention , 1996, Journal of cellular biochemistry. Supplement.
[44] P. Laipis,et al. Multiple Deletions Are Detectable in Mitochondrial DNA of Aging Mice (*) , 1995, The Journal of Biological Chemistry.
[45] S. Zeisel,et al. Choline and hepatocarcinogenesis in the rat. , 1995, Advances in experimental medicine and biology.
[46] A. Groen,et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. , 1994, The American journal of pathology.
[47] N. Nishida,et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.
[48] G. Cooper,et al. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction , 1993, Molecular and cellular biology.
[49] P. Borst,et al. Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.
[50] L. Ellwein,et al. Genetic errors, cell proliferation, and carcinogenesis. , 1991, Cancer research.
[51] E. Farber,et al. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. , 1984, Carcinogenesis.